Vitamin C Common Cold Meta-analysis: What the Evidence Says

Quick Answer

Vitamin C Common Cold Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, guideline, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 guideline.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• We conducted a preliminary search of PubMed, Embase, Cochrane Library, and Web of Science databases, reviewing evidence from their inception to February 17, 2025 on the role of nutritional supplements in preventing respiratory tract infections (RTIs) among adults, with no language restrictions. [Zhu Zhixin (2025); evidence level 1]
• No network meta-analysis (NMA) was found that systematically compared the full range of nutritional interventions for RTI prevention. [Zhu Zhixin (2025); evidence level 1]
• 3 Vitamin C (ascorbic acid) is a key micronutrient that is found naturally in many fruits and vegetables. [Hemilä Harri (2026); evidence level 2]
• (-) 6 7 6 10 This commentary focuses on the effects of vitamin C on respiratory infections and argues that strong evidence supporting the benefits of doses higher than 10 and 40 mg/d in some contexts was overlooked in the formulation of the 1991 recommendations. [Hemilä Harri (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin c common cold meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Zhu Zhixin (2025). Comparative effectiveness of oral nutritional supplements in preventing respiratory tract infections among adults: a systematic review and network meta-analysis. DOI: 10.1016/j.eclinm.2025.103479. PMCID: PMC12441711. PMID: 40969681. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12441711/
• Hemilä Harri (2026). Are the UK’s vitamin C recommendations evidence-based? A critical comment. DOI: 10.1017/S0007114525105941. PMCID: PMC12929015. PMID: 41424103. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12929015/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.